VICKI L. SATO

Corporate Board Profile

Tech Score: 0/100

BORGWARNER INC

Filing Date	Source Excerpt
2015-03-20	Vicki L. Sato Age: 66 Role: Director Committee: Compensation Committee Compensation: $196,993 Excerpt: "Dr. Sato serves as Professor of Management Practice of Harvard Business School..." and "The current members of the Compensation Committee are Directors Drummond (Chairman), Bonanno, Carlson and Sato." and "Vicki L. Sato 82,000 Fees Earned or Paid in Cash, 114,993 Stock Awards, Total 196,993"
2020-03-20	DIRECTOR SINCE 2014 OTHER CURRENTDIRECTORSHIPS Bristol-MyersSquibb Company,Denali Therapeutics, Inc.,Vir Biotechnology, Inc. BORGWARNER COMMITTEES Compensation Chair,Governance Vicki L. Sato, Ph.D., 71 Retired Professor of Management Practice, Harvard Business School ... Dr. Sato's previous roles as chief scientific officer and vice president of research for multinational companies, as well as her academic work on science-driven entrepreneurship, allow her to offer guidance as we develop our technology initiatives and collaborative efforts.

Filing Date

Source Excerpt

2015-03-20

Vicki L. Sato Age: 66 Role: Director Committee: Compensation Committee Compensation: $196,993 Excerpt: "Dr. Sato serves as Professor of Management Practice of Harvard Business School..." and "The current members of the Compensation Committee are Directors Drummond (Chairman), Bonanno, Carlson and Sato." and "Vicki L. Sato 82,000 Fees Earned or Paid in Cash, 114,993 Stock Awards, Total 196,993"

2020-03-20

DIRECTOR SINCE 2014 OTHER CURRENTDIRECTORSHIPS Bristol-MyersSquibb Company,Denali Therapeutics, Inc.,Vir Biotechnology, Inc. BORGWARNER COMMITTEES Compensation Chair,Governance Vicki L. Sato, Ph.D., 71 Retired Professor of Management Practice, Harvard Business School ... Dr. Sato's previous roles as chief scientific officer and vice president of research for multinational companies, as well as her academic work on science-driven entrepreneurship, allow her to offer guidance as we develop our technology initiatives and collaborative efforts.

Data sourced from SEC filings. Last updated: 2026-02-03